A randomized, double-blind phase 2 trial of maintenance sorafenib in epithelial ovarian or primary peritoneal cancer

Category Primary study
ConferenceInternational Journal of Gynecological Cancer
Year 2012
This article has no abstract
Epistemonikos ID: 2a428064b44e2c5f709fd6a0d17605930277001f
First added on: Apr 30, 2026